CUE Cue Biopharma, Inc.

Fundamentals / CIK 0001645460 / USD

Cue Biopharma, Inc. reported $35.64M in revenue and a net loss of $206.7M for the trailing twelve months ended September 30, 2026 (down 93.9% year over year), with a -387.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CUE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$32.67M$16.33M$0-$51.90MFY 2017 Net Income: -$23.23M2017FY 2018 Revenue: $1.14MFY 2018 Net Income: -$38.98M2018FY 2019 Revenue: $3.46MFY 2019 Net Income: -$36.70M2019FY 2020 Revenue: $3.15MFY 2020 Net Income: -$44.78M2020FY 2021 Revenue: $14.94MFY 2021 Net Income: -$44.16M2021FY 2022 Revenue: $1.25MFY 2022 Net Income: -$53.01M2022FY 2023 Revenue: $5.49MFY 2023 Net Income: -$50.73M2023FY 2024 Revenue: $9.29MFY 2024 Net Income: -$40.67M2024FY 2025 Revenue: $27.47MFY 2025 Net Income: -$26.60M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $27.47M $9.29M $5.49M $1.25M $14.94M $3.15M $3.46M $1.14M --
Research & Development $37.74M $36.30M $40.80M $38.58M $41.35M $33.55M $27.49M $28.54M $18.90M
Total Operating Expenses $54.02M $50.79M $57.64M $54.47M $58.65M $48.20M $40.23M $39.84M $23.23M
Operating Income -$26.55M -$41.50M -$52.15M -$53.23M -$43.71M -$45.04M -$36.77M -$38.70M -$23.23M
EBITDA -$25.59M -$41.10M -$51.59M -$52.30M -$42.45M -$43.99M -$35.96M -$37.94M -$22.81M
Interest Expense $100K $100K $100K $109K -- -- -- -- --
Income Before Tax -- -- -- -$53.01M -$43.67M -$44.58M -$36.29M -$38.16M -$23.23M
Income Tax Expense $500K $0 -- $0 $495K $206K $412K $825K --
Net Income -$26.60M -$40.67M -$50.73M -$53.01M -$44.16M -$44.78M -$36.70M -$38.98M -$23.23M
Basic EPS -$8.41 -$21.62 -$33.33 -$44.74 -$42.34 -$46.85 -$49.85 -$58.26 -$64.86
Diluted EPS -$8.41 -$21.62 -$33.33 -$44.74 -$42.34 -$46.85 -$49.85 -$58.26 -$64.86
Basic Shares Outstanding 3.2M 1.9M 1.5M 1.2M 1.0M 955.3K 734.0K 670.5K 357.4K
Diluted Shares Outstanding 3.2M 1.9M 1.5M 1.2M 1.0M 955.3K 734.0K 670.5K 357.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $132K $7.88M $5.69M $21.94M $2.15M $2.95M $421K $1.58M
Research & Development $17.02M $49.01M $6.90M $16.53M $4.75M $7.91M $8.55M $7.18M
Total Operating Expenses $47.23M $95.57M $11.04M $19.96M $9.74M $11.59M $12.72M $11.21M
Operating Income -$47.10M -$87.69M -$5.35M $1.98M -$7.59M -$8.63M -$12.30M -$9.63M
EBITDA -$47.06M -$87.66M -$4.79M $2.66M -$7.51M -$8.54M -$12.20M -$9.54M
Interest Expense -- -- -- $2.0K $33K $33K $100K --
Net Income -$50.02M -$153.1M -$5.18M $1.58M -$7.45M -$8.48M -$12.26M -$9.50M
Basic EPS -$4.74 -$24.14 -$1.08 -- -$2.22 -$2.67 -$4.95 --
Diluted EPS -$4.74 -$24.14 -$1.08 -- -$2.22 -$2.67 -$4.95 --
Basic Shares Outstanding 10.6M 6.3M 4.8M -- 3.4M 3.2M 2.5M --
Diluted Shares Outstanding 10.6M 6.3M 4.8M -- 3.4M 3.2M 2.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $27.14M $22.46M $48.51M $51.61M $64.37M $74.87M $44.29M $20.80M $63.53M
Short-Term Investments -- $0 $0 $24.68M $0 $10.00M $15.12M $18.41M $0
Cash & Short-Term Investments $27.14M $22.46M $48.51M $76.29M $64.40M $84.90M $59.41M $39.21M $63.53M
Accounts Receivable, Net $5.55M $945K $1.70M $57K $3.14M $1.42M $755K -- --
Total Current Assets $36.98M $25.14M $51.45M $77.19M $68.47M $87.53M $61.02M $40.61M $65.07M
Property, Plant & Equipment, Net $241K $471K $795K $1.50M $2.11M $2.11M $1.85M $2.78M $1.69M
Other Non-Current Assets $94K $105K $117K $128K $140K $402K $674K $809K $198K
Total Non-Current Assets $5.23M $7.05M $10.08M $14.10M $14.93M $12.01M $10.58M $4.75M $1.89M
Total Assets $42.21M $32.19M $61.53M $91.28M $83.40M $99.53M $71.61M $45.36M $66.95M
Accounts Payable $3.95M $2.82M $3.50M $2.73M $2.59M $2.07M $883K $2.04M $1.66M
Short-Term Debt -- $37K $4.04M $2.07M -- -- -- -- --
Total Current Liabilities $13.49M $13.69M $17.08M $11.55M $12.79M $16.32M $11.66M $6.22M $5.35M
Long-Term Debt -- $0 $4.20M $8.04M $0 -- -- -- --
Total Non-Current Liabilities $2.29M $1.00M $7.36M $14.05M $5.12M $4.31M $5.37M $5.17M $0
Total Liabilities $15.78M $14.69M $24.45M $25.60M $17.91M $20.62M $17.02M $11.39M $5.35M
Total Debt (incl. Leases) $4.20M $4.58M $8.25M $19.43M $10.05M $7.15M $5.80M -- --
Common Stock $3.0K $62K $47K $43K $32K $30K $27K $21K $19K
Retained Earnings -$368.5M -$341.9M -$301.2M -$250.5M -$197.4M -$153.3M -$108.5M -$71.80M -$32.82M
Accumulated Other Comp. Income -- $0 $0 -$96K $0 $7.1K -$10K -$11K --
Total Stockholders' Equity $26.43M $17.50M $37.09M $65.68M $65.49M $78.91M $54.58M $33.97M $61.61M
Total Equity $26.43M $17.50M $37.09M $65.68M $65.49M $78.91M $54.58M $33.97M $61.61M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $57.94M $17.39M $16.38M $27.14M $11.70M $27.49M $13.14M $22.46M
Short-Term Investments -- -- -- -- $6.97M -- -- $0
Cash & Short-Term Investments $57.94M $17.39M $16.38M $27.14M $18.67M $27.49M $13.14M $22.46M
Accounts Receivable, Net $5.13M $5.38M $5.35M $5.55M $387K $532K $0 $945K
Total Current Assets $66.71M $26.62M $26.39M $36.98M $25.82M $30.84M $15.93M $25.14M
Property, Plant & Equipment, Net $225K $255K $288K $241K $307K $454K $523K $471K
Other Non-Current Assets $85K $88K $90K $94K $96K $283K $102K $105K
Total Non-Current Assets $548K $4.08M $4.49M $5.23M $5.83M $9.86M $6.32M $7.05M
Total Assets $67.25M $30.71M $30.88M $42.21M $31.64M $40.71M $22.25M $32.19M
Accounts Payable $3.61M $3.75M $3.33M $3.95M $2.35M $3.63M $3.78M $2.82M
Short-Term Debt -- -- -- -- -- -- $100K $37K
Total Current Liabilities $19.73M $21.22M $7.39M $13.49M $15.52M $19.25M $15.50M $13.69M
Long-Term Debt -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $9.13M $7.18M $1.88M $2.29M $2.87M $3.29M $176K $1.00M
Total Liabilities $28.86M $28.40M $9.27M $15.78M $18.40M $22.55M $15.67M $14.69M
Total Debt (incl. Leases) -- $3.08M $3.44M $4.20M $4.71M $5.22M $3.85M $4.58M
Common Stock $8.0K $5.0K $3.0K $3.0K $78K $76K $62K $62K
Retained Earnings -$576.7M -$526.7M -$373.6M -$368.5M -$370.1M -$362.6M -$354.1M -$341.9M
Accumulated Other Comp. Income -- -- -- -- $1.0K -- -- $0
Total Stockholders' Equity $38.40M $2.31M $21.61M $26.43M $13.25M $18.16M $6.58M $17.50M
Total Equity $38.40M $2.31M $21.61M $26.43M $13.25M $18.16M $6.58M $17.50M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.60M -$40.67M -$50.73M -$53.01M -$44.16M -$44.78M -$36.70M -$38.98M -$23.23M
Depreciation & Amortization $958K $397K $556K $922K $1.26M $1.06M $811K $760K $420K
Stock-Based Compensation $4.74M $6.85M $8.18M $9.50M $11.52M $10.48M $6.52M $7.17M $2.78M
Change in Receivables -$4.60M $753K -$1.64M $3.08M -$1.73M -$663K -$755K -- --
Change in Payables $1.12M -$678K $770K $83K $520K $741K -$1.15M $376K $922K
Operating Cash Flow -$21.69M -$36.33M -$39.96M -$41.81M -$38.84M -$32.49M -$30.80M -$26.41M -$12.14M
Capital Expenditure -$177K -$66K $0 -$171K -$913K -$595K -$46K -$1.85M -$1.03M
Free Cash Flow -$21.86M -$36.40M -$39.96M -$41.98M -$39.75M -$33.09M -$30.84M -$28.27M -$13.17M
Purchases of Investments -$16.29M $0 -- -- $0 -$9.95M -$15.13M -- --
Investing Cash Flow $75K $32K $25.00M -$24.61M $9.11M $4.46M $3.45M -$20.35M -$1.20M
Common Stock Issued $28.29M $10.81M $0 $22.70M $0 $56.68M $49.00M -- --
Share Repurchases -- -- $0 -$200K -$750K -$271K -$91K -- --
Financing Cash Flow $26.29M $10.24M $11.86M $53.66M $19.23M $58.61M $50.79M $4.18M $62.00M
Net Change in Cash $4.68M -$26.05M -$3.10M -$12.76M -$10.50M $30.58M $23.44M -$42.58M $48.66M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$50.02M -$153.1M -$5.18M $1.58M -$7.45M -$8.48M -$12.26M -$9.50M
Depreciation & Amortization $33K $36K $566K $678K $80K $99K $101K $98K
Stock-Based Compensation $35.48M $23.84M $48K $610K $1.53M $1.26M $1.34M $1.56M
Change in Receivables $245K -$26K $195K -$5.16M $145K -$532K $945K $2.21M
Change in Payables -$139K $421K -$622K $1.60M -$1.28M -$157K $961K -$3.65M
Operating Cash Flow -$10.08M -$29.00M -$10.94M -$1.08M -$9.02M -$3.42M -$8.17M -$9.03M
Capital Expenditure $0 $0 -$121K $0 $0 -$27K -$150K -$2.0K
Free Cash Flow -$10.08M -$29.00M -$11.06M -$1.08M -$9.02M -$3.44M -$8.32M -$9.03M
Investing Cash Flow $0 $0 -$121K $7.02M -$6.77M -$27K -$150K -$1.0K
Financing Cash Flow $50.63M $30.02M $306K $9.49M $1.0K $17.80M -$1.00M -$932K
Net Change in Cash $40.55M $1.01M -$10.76M $15.44M -$15.79M $14.36M -$9.32M -$9.96M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -96.7% -446.9% -949.9% -4275.1% -292.6% -1428.0% -1063.2% -3386.7% --
Net Profit Margin -96.9% -438.0% -924.1% -4257.8% -295.6% -1419.8% -1061.2% -3411.5% --
Return on Equity (ROE) -100.6% -232.4% -136.8% -80.7% -67.4% -56.8% -67.2% -114.7% -37.7%
Return on Assets (ROA) -63.0% -126.4% -82.5% -58.1% -53.0% -45.0% -51.3% -85.9% -34.7%
Current Ratio 2.74x 1.84x 3.01x 6.68x 5.35x 5.36x 5.24x 6.53x 12.17x
Quick Ratio 2.42x 1.71x 2.94x 6.61x 5.28x 5.29x 5.16x 6.31x 11.88x
Debt to Equity 0.16x 0.26x 0.22x 0.30x 0.15x 0.09x 0.11x -- --
Revenue Growth (YoY) +195.7% +69.2% +341.0% -91.7% +373.7% -8.8% +202.7% -- --
5Y Revenue / Share Growth +163.7% +5.1% +111.4% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -387.7% -262.0% -59.9% -96.7% -537.5% -475.2% -514.7% -446.9%
Net Profit Margin -579.9% -435.8% -59.6% -96.9% -530.7% -469.3% -507.9% -438.0%
Return on Equity (ROE) -538.2% -7104.2% -90.4% -100.6% -284.5% -214.2% -616.8% -232.4%
Return on Assets (ROA) -307.3% -534.4% -63.2% -63.0% -119.1% -95.5% -182.4% -126.4%
Current Ratio 3.38x 1.25x 3.57x 2.74x 1.66x 1.60x 1.03x 1.84x
Quick Ratio 3.20x 1.07x 2.94x 2.42x 1.23x 1.46x 0.85x 1.71x
Debt to Equity -- 1.33x 0.16x 0.16x 0.36x 0.29x 0.59x 0.26x
Revenue Growth (YoY) -93.9% +166.7% +1250.6% +1292.3% -35.6% +11.1% -75.5% -13.5%
Source: SEC EDGAR CompanyFacts (CIK 0001645460) · from March 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal